학술논문
Astegolimab or Efmarodocokin Alfa in Patients with Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial∗
Document Type
Article
Author
Source
In: Critical Care Medicine . (Critical Care Medicine, 1 January 2023, 51(1):103-116)
Subject
Language
English
ISSN
15300293
00903493
00903493